| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b53290ef881bc16e92cfbaf0cd9605a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2005-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9fdcf1269824f6e4c051ca7ec6343b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64fd04a5cdcc9c66410d32896af5faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65df49f46a12aa4f4ba266ed26e3a994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6d58a27f731e22f7d28f18ae71baba |
| publicationDate |
2010-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2229919-A2 |
| titleOfInvention |
Bioresorbable stent with beneficial agent reservoirs |
| abstract |
The invention provides an anti-restenotic drug for use in a method of reducing restenosis with a bioresorbable drug delivery stent, the method comprising: providing a drug delivery bioresorbable stent with a dosage of the anti-restenotic drug arranged within a plurality of openings in the stent without coating an exterior surface of the stent with the anti-restenotic drug; implanting the stent within an artery of a patient; and delivering the anti-restenotic drug from the stent to the artery at a minimum release rate of 1 percent of the total dosage of the drug on the stent per day throughout an entire administration period from the time of implantation of the stent until the time that substantially all the drug is released from the stent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9943426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11622872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10076431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786374-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383750-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10271976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017200956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3861961-A1 |
| priorityDate |
2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |